Effects of conventional heparin and low-molecular-weight heparin treatment on lipid metabolism during a single hemodialysis session.
Camsari
T
T
Cavdar
C
C
Oztüre
H
H
Onvural
B
B
Semin
I
I
Celik
A
A
Kavukçu
S
S
D000925:Anticoagulants / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008055:Lipids / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D014280:Triglycerides / Q000097:blood
D000925:Anticoagulants; D005230:Fatty Acids, Nonesterified; D006495:Heparin, Low-Molecular-Weight; D008055:Lipids; D008075:Lipoproteins, HDL; D014280:Triglycerides; D006493:Heparin; D002784:Cholesterol